Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
CNS Spectrums|November 21, 2014
Treatment resistance and other complicating factors in the management of schizophreniaMartin T Strassnig, Philip D Harvey
The Journal of Clinical Psychiatry|July 3, 2009
Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnessesJohn W Newcomer
Clinical Therapeutics|April 13, 2005
Metabolic risk during antipsychotic treatmentJohn W Newcomer
The Journal of Clinical Psychiatry|August 19, 2007
Antipsychotic medications: metabolic and cardiovascular riskJohn W Newcomer
CNS Drugs|July 7, 2005
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature reviewJohn W Newcomer
The American Journal of Managed Care|December 6, 2007
Metabolic syndrome and mental illnessJohn W Newcomer
The Journal of Clinical Psychiatry|December 17, 2004
Abnormalities of glucose metabolism associated with atypical antipsychotic drugsJohn W Newcomer
The Journal of Clinical Psychiatry|January 5, 2007
Medical risk in patients with bipolar disorder and schizophreniaJohn W Newcomer
The Journal of Clinical Psychiatry|September 13, 2006
Medical risk in patients with bipolar disorder and schizophreniaJohn W Newcomer
The Journal of Clinical Psychiatry|February 9, 2007
Metabolic considerations in the use of antipsychotic medications: a review of recent evidenceJohn W Newcomer
Pageof 13